We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$585M
AUM Growth
+$25.3M
Cap. Flow
-$29M
Cap. Flow %
-4.96%
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$3.6M
2
NVDA icon
NVIDIA
NVDA
+$1.81M
3
NTRA icon
Natera
NTRA
+$1.51M
4
PFE icon
Pfizer
PFE
+$1.41M
5
S icon
SentinelOne
S
+$706K

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.86M
2
MSFT icon
Microsoft
MSFT
+$2.82M
3
MA icon
Mastercard
MA
+$2.78M
4
CMCSA icon
Comcast
CMCSA
+$2.56M
5
AAPL icon
Apple
AAPL
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 35%
2 Healthcare 14.27%
3 Consumer Discretionary 13.55%
4 Communication Services 11.79%
5 Financials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
326
DELISTED
Marathon Oil Corporation
MRO
$10K ﹤0.01%
616
KD icon
327
Kyndryl
KD
$3.07B
$9K ﹤0.01%
+479
New +$10.3K
ALL icon
328
Allstate
ALL
$67.6B
$8K ﹤0.01%
68
STT icon
329
State Street
STT
$50.5B
$8K ﹤0.01%
83
APA icon
330
APA Corp
APA
$13B
$6K ﹤0.01%
228
SLVM icon
331
Sylvamo
SLVM
$1.52B
$5K ﹤0.01%
+165
New +$4.81K
AIV
332
Aimco
AIV
$387M
$4K ﹤0.01%
505
ONL
333
Orion Office REIT
ONL
$155M
$1K ﹤0.01%
+29
New +$573
ALLK
334
DELISTED
Allakos
ALLK
-2,242
Closed -$237K
CDLX icon
335
Cardlytics
CDLX
$23.6M
-377
Closed -$316K
RPAY icon
336
Repay Holdings
RPAY
$343M
-9,958
Closed -$229K
EVBG
337
DELISTED
Everbridge, Inc. Common Stock
EVBG
-2,118
Closed -$320K
RETA
338
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-3,483
Closed -$350K

Similar funds

Silvant Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.

  • Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
  • Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
  • Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
  • Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
  • Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
  • Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
  • Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.

Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.